IL129191A0 - Derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity - Google Patents

Derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity

Info

Publication number
IL129191A0
IL129191A0 IL12919199A IL12919199A IL129191A0 IL 129191 A0 IL129191 A0 IL 129191A0 IL 12919199 A IL12919199 A IL 12919199A IL 12919199 A IL12919199 A IL 12919199A IL 129191 A0 IL129191 A0 IL 129191A0
Authority
IL
Israel
Prior art keywords
phenoxymethyl
tetrazole
derivatives
acetic acid
antitumor activity
Prior art date
Application number
IL12919199A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL129191A0 publication Critical patent/IL129191A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12919199A 1998-03-30 1999-03-26 Derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity IL129191A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98105726A EP0947511A1 (en) 1998-03-30 1998-03-30 Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity

Publications (1)

Publication Number Publication Date
IL129191A0 true IL129191A0 (en) 2000-02-17

Family

ID=8231677

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12919199A IL129191A0 (en) 1998-03-30 1999-03-26 Derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity

Country Status (20)

Country Link
EP (1) EP0947511A1 (id)
JP (1) JP2000063340A (id)
KR (1) KR19990078366A (id)
CN (1) CN1232028A (id)
AR (1) AR018170A1 (id)
AU (1) AU2250299A (id)
BR (1) BR9901208A (id)
CA (1) CA2267047A1 (id)
HR (1) HRP990093A2 (id)
HU (1) HUP9900804A3 (id)
ID (1) ID22335A (id)
IL (1) IL129191A0 (id)
MA (1) MA26616A1 (id)
NO (1) NO991526L (id)
NZ (1) NZ334874A (id)
PE (1) PE20000341A1 (id)
PL (1) PL332273A1 (id)
SG (1) SG81972A1 (id)
TR (1) TR199900719A2 (id)
ZA (1) ZA992407B (id)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841900B1 (fr) 2002-07-08 2007-03-02 Genfit S A Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations
FR2841784B1 (fr) * 2002-07-08 2007-03-02 Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations
AU2004253245B2 (en) * 2003-06-17 2010-02-11 F. Hoffmann-La Roche Ag CIS-imidazolines as MDM2 inhibitors
FR2857361B1 (fr) * 2003-07-08 2005-09-09 Genfit S A PREPARATION DE DERIVES DE 1,3-DIPHENYPROP-2-¼n-1-one
WO2005063774A1 (en) * 2003-12-22 2005-07-14 Johns Hopkins University Boronic acid aryl analogs
JP2007297283A (ja) * 2004-07-28 2007-11-15 Santen Pharmaceut Co Ltd 新規桂皮酸関連化合物
SG174107A1 (en) * 2006-08-30 2011-09-29 Univ Michigan New small molecule inhibitors of mdm2 and the uses thereof
CN101516366B (zh) 2006-09-21 2012-05-30 霍夫曼-拉罗奇有限公司 作为抗癌剂的羟吲哚衍生物
US7638548B2 (en) 2006-11-09 2009-12-29 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US7553833B2 (en) 2007-05-17 2009-06-30 Hoffmann-La Roche Inc. 3,3-spiroindolinone derivatives
US7928233B2 (en) 2009-02-10 2011-04-19 Hoffmann-La Roche Inc. Spiroindolinone pyridine derivatives
US8217051B2 (en) 2009-02-17 2012-07-10 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US8076482B2 (en) 2009-04-23 2011-12-13 Hoffmann-La Roche Inc. 3,3′-spiroindolinone derivatives
US8017607B2 (en) 2009-10-14 2011-09-13 Hoffmann-La Roche Inc. N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions
US8088815B2 (en) 2009-12-02 2012-01-03 Hoffman-La Roche Inc. Spiroindolinone pyrrolidines
US8288431B2 (en) 2010-02-17 2012-10-16 Hoffmann-La Roche Inc. Substituted spiroindolinones
US8217044B2 (en) 2010-04-28 2012-07-10 Hoffmann-La Roche Inc. Spiroindolinone pyrrolidines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255241A (en) * 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
NL300456A (id) * 1962-11-13
US3251064A (en) * 1962-11-13 1966-05-10 Everett M Schultz beta-aminoacylphenoxy-and beta-aminoacylphenylmercapto-derivatives of monocarboxylicacids
US3994955A (en) * 1975-01-20 1976-11-30 G. D. Searle & Co. Substituted phenoxydialkylacetic acids and esters
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
JPH0624975A (ja) * 1992-05-12 1994-02-01 Dainippon Ink & Chem Inc 制癌活性増強剤
DE4327365A1 (de) * 1993-08-14 1995-02-16 Boehringer Mannheim Gmbh Verwendung von Phenolen und Phenolderivaten als Arzneimittel mit fibrinogensenkender Wirkung

Also Published As

Publication number Publication date
TR199900719A2 (xx) 1999-10-21
HU9900804D0 (en) 1999-05-28
AR018170A1 (es) 2001-10-31
NO991526L (no) 1999-10-01
MA26616A1 (fr) 2004-12-20
PL332273A1 (en) 1999-10-11
HRP990093A2 (en) 2000-02-29
HUP9900804A2 (hu) 1999-11-29
PE20000341A1 (es) 2000-05-08
CA2267047A1 (en) 1999-09-30
BR9901208A (pt) 2000-04-25
CN1232028A (zh) 1999-10-20
KR19990078366A (ko) 1999-10-25
JP2000063340A (ja) 2000-02-29
HUP9900804A3 (en) 2001-08-28
NZ334874A (en) 2000-08-25
NO991526D0 (no) 1999-03-29
AU2250299A (en) 1999-10-14
EP0947511A1 (en) 1999-10-06
SG81972A1 (en) 2001-07-24
ZA992407B (en) 1999-09-30
ID22335A (id) 1999-09-30

Similar Documents

Publication Publication Date Title
HU9900804D0 (en) Derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity
HUP0002224A3 (en) Benzimidazole derivatives of antivirus activity
AU7051000A (en) Method of activity based costing
PL338633A1 (en) Derivatives of aryloxyarylsuphonylamino hydroxamic acid
PL335027A1 (en) Derivatives of arylsulphonylamino hydroxamic acid
HUP0202477A3 (en) Use of phthalazine derivatives
HU9701299D0 (en) Insuline derivatives of enhanced zinc-binding activity
PL344977A1 (en) Therapeutic uses of quinoline derivatives
AU7710300A (en) Methods for diagnosis and therapy of hematological and virus-associated malignancies
AU4717301A (en) Catheter assembly and method of use
AU5668499A (en) Veneer tape and method of use
AU3522999A (en) Purification of human acid alpha-glucosidase
AU3669200A (en) Detection of smooth muscle motor activity
HU9904659D0 (en) Aryl carboxylic acid and tetrazole derivatives
HU9800373D0 (en) Steroide compounds of anticeptive and antiosteoporosive activity
PL335601A1 (en) Derivatives of 2-substituted benzoylcycloalkyl carboxylic acid
AU6500600A (en) Methods and compositions for determining enzymatic activity
AU7608100A (en) 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors
HUP0102073A3 (en) Hydroxamic and carboxylic acid derivatives and medicaments containing them
AU5530800A (en) Method and composition for enhancing the activity of an enzyme
AU1143601A (en) Method and composition for enhancing the activity of an enzyme
PL354481A1 (en) Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4
AU2565600A (en) Determination of nuclease activity
AUPQ327999A0 (en) Girder bracket and method of fastening thereof
AU1386501A (en) Method and composition for enhancing the activity of an enzyme